guest ::
| Home > Publications database > FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma. > print |
| Home > Publications database > FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma. > print |
| 001 | 130382 | ||
| 005 | 20240228143429.0 | ||
| 024 | 7 | _ | |a 10.15252/embj.201693889 |2 doi |
| 024 | 7 | _ | |a pmid:27625374 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC5069553 |2 pmc |
| 024 | 7 | _ | |a 0261-4189 |2 ISSN |
| 024 | 7 | _ | |a 1460-2075 |2 ISSN |
| 024 | 7 | _ | |a altmetric:12011518 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2017-05461 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Suryo Rahmanto, Aldwin |0 0000-0002-4593-286X |b 0 |
| 245 | _ | _ | |a FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma. |
| 260 | _ | _ | |a Heidelberg |c 2016 |b EMBO Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1522137396_18537 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a SOX9 is a master transcription factor that regulates development and stem cell programs. However, its potential oncogenic activity and regulatory mechanisms that control SOX9 protein stability are poorly understood. Here, we show that SOX9 is a substrate of FBW7, a tumor suppressor, and a SCF (SKP1/CUL1/F-box)-type ubiquitin ligase. FBW7 recognizes a conserved degron surrounding threonine 236 (T236) in SOX9 that is phosphorylated by GSK3 kinase and consequently degraded by SCF(FBW)(7α) Failure to degrade SOX9 promotes migration, metastasis, and treatment resistance in medulloblastoma, one of the most common childhood brain tumors. FBW7 is either mutated or downregulated in medulloblastoma, and in cases where FBW7 mRNA levels are low, SOX9 protein is significantly elevated and this phenotype is associated with metastasis at diagnosis and poor patient outcome. Transcriptional profiling of medulloblastoma cells expressing a degradation-resistant SOX9 mutant reveals activation of pro-metastatic genes and genes linked to cisplatin resistance. Finally, we show that pharmacological inhibition of PI3K/AKT/mTOR pathway activity destabilizes SOX9 in a GSK3/FBW7-dependent manner, rendering medulloblastoma cells sensitive to cytostatic treatment. |
| 536 | _ | _ | |a 312 - Functional and structural genomics (POF3-312) |0 G:(DE-HGF)POF3-312 |c POF3-312 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a 4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide |2 NLM Chemicals |
| 650 | _ | 7 | |a AZD2014 |2 NLM Chemicals |
| 650 | _ | 7 | |a AZD8186 |2 NLM Chemicals |
| 650 | _ | 7 | |a Aniline Compounds |2 NLM Chemicals |
| 650 | _ | 7 | |a Cell Cycle Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a Chromones |2 NLM Chemicals |
| 650 | _ | 7 | |a F-Box Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a Morpholines |2 NLM Chemicals |
| 650 | _ | 7 | |a Protein Kinase Inhibitors |2 NLM Chemicals |
| 650 | _ | 7 | |a Pyrimidines |2 NLM Chemicals |
| 650 | _ | 7 | |a Pyrroles |2 NLM Chemicals |
| 650 | _ | 7 | |a SOX9 Transcription Factor |2 NLM Chemicals |
| 650 | _ | 7 | |a SOX9 protein, human |2 NLM Chemicals |
| 650 | _ | 7 | |a Ubiquitin-Protein Ligases |0 EC 2.3.2.27 |2 NLM Chemicals |
| 650 | _ | 7 | |a Phosphatidylinositol 3-Kinases |0 EC 2.7.1.- |2 NLM Chemicals |
| 650 | _ | 7 | |a MTOR protein, human |0 EC 2.7.1.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a TOR Serine-Threonine Kinases |0 EC 2.7.1.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a Proto-Oncogene Proteins c-akt |0 EC 2.7.11.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a Glycogen Synthase Kinase 3 |0 EC 2.7.11.26 |2 NLM Chemicals |
| 650 | _ | 7 | |a FBXW7 protein, human |0 EC 6.3.2.19 |2 NLM Chemicals |
| 650 | _ | 7 | |a Cisplatin |0 Q20Q21Q62J |2 NLM Chemicals |
| 700 | 1 | _ | |a Savov, Vasil |b 1 |
| 700 | 1 | _ | |a Brunner, Andrä |b 2 |
| 700 | 1 | _ | |a Bolin, Sara |b 3 |
| 700 | 1 | _ | |a Weishaupt, Holger |b 4 |
| 700 | 1 | _ | |a Malyukova, Alena |b 5 |
| 700 | 1 | _ | |a Rosén, Gabriela |b 6 |
| 700 | 1 | _ | |a Čančer, Matko |b 7 |
| 700 | 1 | _ | |a Hutter, Sonja |0 P:(DE-He78)81d14a5d74f69c16e5e1cd0144cd955c |b 8 |u dkfz |
| 700 | 1 | _ | |a Sundström, Anders |b 9 |
| 700 | 1 | _ | |a Kawauchi, Daisuke |0 P:(DE-He78)0ac2bd1a9fb1823a351ee4434d80808b |b 10 |u dkfz |
| 700 | 1 | _ | |a Jones, David |0 P:(DE-He78)551bb92841f634070997aa168d818492 |b 11 |u dkfz |
| 700 | 1 | _ | |a Spruck, Charles |b 12 |
| 700 | 1 | _ | |a Taylor, Michael D |b 13 |
| 700 | 1 | _ | |a Cho, Yoon-Jae |b 14 |
| 700 | 1 | _ | |a Pfister, Stefan |0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |b 15 |u dkfz |
| 700 | 1 | _ | |a Kool, Marcel |0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8 |b 16 |u dkfz |
| 700 | 1 | _ | |a Korshunov, Andrey |0 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93 |b 17 |u dkfz |
| 700 | 1 | _ | |a Swartling, Fredrik J |0 0000-0002-8460-4367 |b 18 |
| 700 | 1 | _ | |a Sangfelt, Olle |0 0000-0002-0316-0195 |b 19 |
| 773 | _ | _ | |a 10.15252/embj.201693889 |g Vol. 35, no. 20, p. 2192 - 2212 |0 PERI:(DE-600)1467419-1 |n 20 |p 2192 - 2212 |t The EMBO journal |v 35 |y 2016 |x 1460-2075 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:130382 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)81d14a5d74f69c16e5e1cd0144cd955c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)0ac2bd1a9fb1823a351ee4434d80808b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)551bb92841f634070997aa168d818492 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |2 G:(DE-HGF)POF3-300 |v Functional and structural genomics |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2016 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EMBO J : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EMBO J : 2015 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l Pädiatrische Neuroonkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)G380-20160331 |k G380 |l KKE Neuropathologie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G380-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|